Bringing together talented scientists in one state-of-the-art space is the first step, in a new era of emerging and vector-borne infectious disease research at Colorado State University.
There are approximately 4,700 active research projects at CSU and in the last fiscal year, 78% were funded by federal agencies. Forty-four are COVID-related including the development of four vaccine candidates.
The research team used existing technologies to treat nine plasma and three whole-blood products.
CSU investigators will run tests for up to 45,000 workers and nursing home residents in the state.
Dr. Amy MacNeill and her team are using the vaccinia virus – used as the very first vaccine, for smallpox – to make a vaccine that would protect against coronavirus.
Over the last two months, a team at CSU tested samples from 462 healthcare workers in Colorado.